Validity and Reliability of the Postural Habits and Awareness Scale

September 19, 2025 updated by: Abdurrahman Tanhan, Bitlis Eren University

Validity and Reliability of the Postural Habits and Awareness Scale in Patients Diagnosed With Fibromyalgia in Turkey

The aim of this study was to examine the validity and reliability of the Turkish version of the Postural Habits and Awareness Scale in Fibromyalgia patients.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Postural Habit and Awareness Scale is a scale developed for healthy individuals. For this reason, when applying to any disease group, other parameters belonging to that disease group should also be evaluated. For this purpose, Fibromyalgia Impact Questionnaire, Body Perception Scale, Body Awareness Questionnaire, Visual Analog Scale and Short Form-12 questionnaires were also used in the study. Fibromyalgia is a disease that affects the whole body and generally causes pain and stiffness complaints. For this reason, the whole body should be evaluated. Fibromyalgia Impact Questionnaire was used to define and indicate the level of fibromyalgia effects of the patients. For validity and reliability analyses, Body Perception Scale and Body Awareness Questionnaire questionnaires were used to compare the Postural Habit and Awareness scale. At the same time, Short Form-12 questionnaire was used to examine the patients' pain severity and the effects of the disease on daily life.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Merkez
      • Bitlis, Merkez, Turkey (Türkiye), 13000
        • Bitlis Eren University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Fibromyalgia

Description

Inclusion Criteria:

  • Those who have been diagnosed with Fibromyalgia according to the American Rheumatology Association criteria and have been over for at least 6 months,
  • Those who do not have a history of any psychiatric disease,
  • Those who have the ability to lie down, sit and stand without any assistance.

Exclusion Criteria:

  • Pregnant individuals,
  • Those who have pain complaints due to another disease (rheumatic, heart or infectious diseases),
  • Those who make changes in physical activity and lifestyle during work,
  • Those with any neurological disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Postural Habit and Awareness Scale
Time Frame: 7-10 days
Developed by Turkish researchers Bayar and his colleagues, the scale has 19 items and four factors. The factors of the scale are posture habits and awareness, awareness of factors that disrupt posture, positional awareness and ergonomic awareness. Postural habits are examined with seven items and postural awareness is examined with twelve items in the scale. Scoring is 5-point Likert type, the minimum score is one for each proposition; the maximum score is five. The total score is a maximum of 95.
7-10 days

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Fibromyalgia Impact Questionnaire
Time Frame: 2 days
The questionnaire consists of 10 propositions. It is a tool that allows the patient to evaluate themselves in terms of physical function, work status, depression, anxiety, sleep, pain, stiffness, fatigue and feeling good. The questionnaire has a 4-point Likert structure and the scoring varies between 0-3. A high score means that physical disability increases
2 days
Body Perception Scale
Time Frame: 2 days
It is a tool that allows the patient to evaluate their body perception themselves. It consists of 46 items in total. The scale is scored between 1-5, with a high score indicating poor body image.
2 days
Body Awareness Questionnaire
Time Frame: 2 days
This questionnaire is designed to determine the normal and/or abnormal sensitivity level of an individual's body composition. This questionnaire consists of four subgroups. These subgroups are; changes in body processes, sleep-wake cycle, prediction at the beginning of the disease, prediction of body reactions. BFA is a 7-point Likert type scale and consists of 18 items in total. Each item is scored between 1-7. The lowest possible score is 18, and the highest score is 126
2 days
Visual Analog Scale
Time Frame: 2 days
VAS is a reliable and easily applicable scale that is accepted in the literature and used to measure the pain intensity of patients. The patient is asked to mark the part that represents the pain intensity on a straight line between 0-10 cm. The "0" at the beginning indicates no pain, and the "10" at the end indicates the presence of very severe, unbearable pain
2 days
Short Form-12
Time Frame: 2 days
This form; It consists of 8 sub-dimensions and 12 items: physical functioning, physical role, body pain, general health, energy, social functioning, emotional role and mental health. The Physical Component Summary and Mental Component Summary scores of the scale are calculated separately. The Physical Component Summary -12 score is obtained from the general health, physical functioning, physical role and body pain sub-dimensions. The Mental Component Summary -12 score is scored with the social functioning, emotional role, mental health and energy sub-dimensions. The scores of both sub-dimensions vary between 0-100. A higher score indicates a better quality of life.
2 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Bitlis Eren University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 25, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 30, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 30, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
June 3, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 3, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 11, 2025

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
September 23, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 19, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
September 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • BitlisErenU3

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fibromyalgia

Clinical Trials on Validation and Reability study

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings